文献速递胃肠外科围术期管理与 ERAS

胃电刺激与胃切除术治疗难治性胃轻瘫的比较

Gastric electric stimulator versus gastrectomy for the treatment of medically refractory gastroparesis.
PubMed 文献 · Surg Endosc · 2022-03-25

该回顾性研究分析了181例难治性胃轻瘫患者,比较胃电刺激(GES)与腹腔镜胃切除术(LG)的临床结局。GES组术后主要院内并发症发生率较低(5% vs 18%),住院时间较短(3 vs 9天),但随访期间症状改善的可能性较低(OR 0.160)。术后病因与GES失败及转为LG相关。

要点

  • GES组糖尿病胃轻瘫比例更高(67% vs 39%),LG组术后胃轻瘫比例更高(43% vs 5%)。
  • LG组主要院内并发症发生率更高(18% vs 5%),住院时间更长(9 vs 3天)。
  • GES作为主要干预措施与随访症状改善可能性较低相关(OR 0.160)。

核心结论

  • GES作为难治性胃轻瘫的一线手术治疗与LG相比结局更差。
  • 术后病因与GES失败可能性增加相关,此类患者 upfront 胃切除术可能是更优选择。

研究设计与样本

  • 数据收集包括病历回顾和随访电话调查,统计分析采用卡方检验、方差分析和多变量逻辑回归。

主要发现

  • 130例(72%)接受GES,51例(28%)接受LG作为主要干预。
  • GES组糖尿病胃轻瘫比例更高(GES 67% vs LG 39%,p < 0.001),LG组术后胃轻瘫比例更高(GES 5% vs LG 43%,p < 0.001)。
  • LG组主要院内并发症发生率更高(GES 5% vs LG 18%,p = 0.017),住院时间更长(GES 3 vs LG 9天,p < 0.001)。
  • 平均35个月随访期间,主要并发症、再入院或死亡率无差异。
  • 多变量回归显示GES作为主要干预的患者随访症状改善可能性较低,OR 0.160(95% CI 0.048-0.532)。

临床怎么用

  • 对于难治性胃轻瘫,GES作为一线手术治疗与LG相比结局更差。
  • 术后病因患者GES失败可能性增加, upfront 胃切除术可能是更优替代方案。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gastric electrical stimulation (GES) and laparoscopic gastrectomy (LG) are known therapeutic options for medically refractory gastroparesis (MRG) although there are limited data comparing their outcomes. We aim to compare clinical outcomes between patients undergoing GES vs upfront LG for the treatment of MRG while examining factors associated with GES failure and conversion to LG. METHODS: We retrospectively analyzed 181 consecutive patients who underwent GES or LG for MRG at our institution from January 2003 to December 2017. Data collection consisted of chart review and follow-up telephone survey. Statistical analysis utilized Chi-squared, ANOVA, and multivariable logistic regression. RESULTS: Overall, 130 (72%) patients underwent GES and 51 (28%) LG as primary intervention. GES patients were more likely to have diabetic gastroparesis (GES 67% vs LG 39%, p < 0.001), while primary LG patients were more likely to have post-surgical gastroparesis (GES 5% vs LG 43%, p < 0.001). Postoperatively, primary LG patients had higher rates of major in-hospital morbidity events (GES 5% vs LG 18%, p = 0.017) and longer hospital stays (GES 3 vs LG 9 days, p < 0.001). However, over a mean 35-month follow-up period, there were no differences in the rates of major morbidity, readmissions, or mortality. Multivariable regression analysis revealed patients undergoing GES as a primary intervention were less likely to report improvement in symptoms on follow-up compared to primary LG patients OR 0.160 (95% CI 0.048-0.532). Additionally, patients who converted to LG from GES were more likely to have post-surgical gastroparesis as the primary etiology. CONCLUSION: GES as a first-line surgical treatment of MRG was associated with worse outcomes compared to LG. Post-surgical etiology was associated with an increased likelihood of GES failure, and in such patients, upfront gastrectomy may be a superior alternative to GES. Further studies are needed to determine patient selection for operative treatment of MRG.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Samaan JS, Toubat O, Alicuben ET, et al. Gastric electric stimulator versus gastrectomy for the treatment of medically refractory gastroparesis. Surg Endosc. 2022. PMID: 35338403. doi:10.1007/s00464-022-09191-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。